Your browser doesn't support javascript.
loading
Structure-function correlates of vision loss in neuromyelitis optica spectrum disorders.
Gigengack, Norman K; Oertel, Frederike C; Motamedi, Seyedamirhosein; Bereuter, Charlotte; Duchow, Ankelien; Rust, Rebekka; Bellmann-Strobl, Judith; Ruprecht, Klemens; Schmitz-Hübsch, Tanja; Paul, Friedemann; Brandt, Alexander U; Zimmermann, Hanna G.
Affiliation
  • Gigengack NK; Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecule Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.
  • Oertel FC; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Motamedi S; Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecule Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.
  • Bereuter C; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Duchow A; Department of Neurology, University of California San Francisco, San Francisco, CA, USA.
  • Rust R; Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecule Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.
  • Bellmann-Strobl J; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Ruprecht K; Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecule Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.
  • Schmitz-Hübsch T; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Paul F; Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecule Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.
  • Brandt AU; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Zimmermann HG; Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecule Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.
Sci Rep ; 12(1): 17545, 2022 10 20.
Article in En | MEDLINE | ID: mdl-36266394
ABSTRACT
Optic neuritis (ON) in neuromyelitis optica spectrum disorders (NMOSD) regularly leads to more profound vision loss compared to multiple sclerosis (MS) and myelin-oligodendrocyte-glycoprotein-antibody associated disease (MOGAD). Here we investigate ON-related vision loss in NMOSD compared to MS and MOGAD in order to identify neuroaxonal and retinal contributors to visual dysfunction. In this retrospective study we included patients with aquaporin-4-antibody seropositive NMOSD (n = 28), MOGAD (n = 14), MS (n = 29) and controls (n = 14). We assessed optic nerve damage and fovea morphometry by optical coherence tomography. Visual function was assessed as high (HCVA) and low contrast visual acuity (LCVA), and visual fields' mean deviation (MD). In all diseases, lower visual function was associated with peripapillary retinal nerve fiber layer (pRNFL) and ganglion cell and inner plexiform layer (GCIP) thinning following a broken stick model, with pRNFL and GCIP cutoff point at ca. 60 µm. HCVA loss per µm pRNFL and GCIP thinning was stronger in NMOSD compared with MOGAD. Foveal inner rim volume contributed to MD and LCVA in NMOSD eyes, only. Together these data supports that visual dysfunction in NMOSD is associated with neuroaxonal damage beyond the effect seen in MS and MOGAD. A primary retinopathy, respectively Müller cell pathology, may contribute to this effect.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Optic Neuritis / Neuromyelitis Optica / Aquaporins / Multiple Sclerosis Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Sci Rep Year: 2022 Document type: Article Affiliation country: Alemania

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Optic Neuritis / Neuromyelitis Optica / Aquaporins / Multiple Sclerosis Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Sci Rep Year: 2022 Document type: Article Affiliation country: Alemania